Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Feldman

Showing results (61-70 of 211) with videos related to

Pageof 22
Sort By:
Journal of Health Care for the Poor and Underserved|August 7, 2007
Outreach to immigrant communities: teaching pediatric residents about access to health careRobert J Karp, David Rhee, David Feldman, et al.
Endocrinology|October 13, 2009
Modulation of vitamin d receptor activity by the corepressor hairless: differential effects of hairless isoformsPeter J Malloy, Jining Wang, Kristin Jensen, et al.
International Journal of Cancer|October 6, 2007
The role of insulin-like growth factor binding protein-3 in the growth inhibitory actions of androgens in LNCaP human prostate cancer cellsLihong Peng, Jining Wang, Peter J Malloy, et al.
Urology|May 16, 2006
Phase II study evaluating oral triamcinolone in patients with androgen-independent prostate cancerSandy Srinivas, Aruna V Krishnan, Natalia Colocci, et al.
American Family Physician|February 10, 2010
Cardiomyopathy: an overviewRandell K Wexler, Terry Elton, Adam Pleister, et al.
Endocrinology|December 6, 2008
Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cellsPeter J Malloy, Lihong Peng, Jining Wang, et al.
The American Journal of Clinical Nutrition|March 24, 2012
Relations between obesity, insulin resistance, and 25-hydroxyvitamin DCynthia A Lamendola, Danit Ariel, David Feldman, et al.
The Journal of Urology|September 28, 2002
Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cellsDonna M Peehl, Eugene Seto, Ju-Yu Hsu, et al.
Molecular Cancer Therapeutics|July 5, 2006
Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cellsRumi S Bhattacharyya, Aruna V Krishnan, Srilatha Swami, et al.
The Prostate|March 30, 2012
Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancerJennifer Y Wang, Srilatha Swami, Aruna V Krishnan, et al.
Pageof 22

Showing results (61-70 of 211) with videos related to

Sort By:
Pageof 22
Journal of Health Care for the Poor and Underserved|August 7, 2007
Outreach to immigrant communities: teaching pediatric residents about access to health careRobert J Karp, David Rhee, David Feldman, et al.
Endocrinology|October 13, 2009
Modulation of vitamin d receptor activity by the corepressor hairless: differential effects of hairless isoformsPeter J Malloy, Jining Wang, Kristin Jensen, et al.
International Journal of Cancer|October 6, 2007
The role of insulin-like growth factor binding protein-3 in the growth inhibitory actions of androgens in LNCaP human prostate cancer cellsLihong Peng, Jining Wang, Peter J Malloy, et al.
Urology|May 16, 2006
Phase II study evaluating oral triamcinolone in patients with androgen-independent prostate cancerSandy Srinivas, Aruna V Krishnan, Natalia Colocci, et al.
American Family Physician|February 10, 2010
Cardiomyopathy: an overviewRandell K Wexler, Terry Elton, Adam Pleister, et al.
Endocrinology|December 6, 2008
Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cellsPeter J Malloy, Lihong Peng, Jining Wang, et al.
The American Journal of Clinical Nutrition|March 24, 2012
Relations between obesity, insulin resistance, and 25-hydroxyvitamin DCynthia A Lamendola, Danit Ariel, David Feldman, et al.
The Journal of Urology|September 28, 2002
Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cellsDonna M Peehl, Eugene Seto, Ju-Yu Hsu, et al.
Molecular Cancer Therapeutics|July 5, 2006
Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cellsRumi S Bhattacharyya, Aruna V Krishnan, Srilatha Swami, et al.
The Prostate|March 30, 2012
Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancerJennifer Y Wang, Srilatha Swami, Aruna V Krishnan, et al.
Pageof 22